2-fluoropyrimidine

proteasome 26S subunit, non-ATPase 1 ; Homo sapiens







137 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30673966 Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer. 2019 Jun 1
2 29931401 Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. 2018 Jul 1
3 30345049 Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study. 2018 Nov 1
4 26715117 Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. 2017 Jan 1
5 27189323 A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer. 2017 Mar 1
6 27255289 Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer. 2017 Mar 1
7 27980246 Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer. 2017 Jan 1
8 28760152 Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study. 2017 Jul 31 1
9 28794362 Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine. 2017 Sep 1 1
10 29191594 A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202. 2017 Oct 1
11 29696197 Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial. 2017 Dec 1
12 26606381 A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer. 2016 1
13 26830752 Pancreatic cancer. 2016 Jul 2 1
14 26915359 Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. 2016 Feb 25 1
15 27067680 [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer]. 2016 Feb 1
16 27207886 Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701. 2016 Aug 1
17 27339150 Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer. 2016 Aug 1
18 27468920 Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study). 2016 Sep 1
19 25422155 Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer. 2015 Jan 1
20 26019463 Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. 2015 May 21 1
21 24258457 A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer. 2014 Feb 1
22 24895802 Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer. 2014 Jan-Feb 1
23 24918280 [Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1]. 2014 1
24 24942277 S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial). 2014 Sep 1
25 25032886 Efficacy of S-1 in colorectal cancer. 2014 Aug 1
26 25109221 Efficacy of S-1 in non-small cell lung cancer. 2014 Sep 1
27 25453619 Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer. 2014 Dec 1
28 25606031 Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin. 2014 Sep-Dec 1
29 22623066 A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer. 2013 Jun 1
30 23558513 Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer. 2013 Jun 15 1
31 23763511 Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). 2013 Sep 1
32 23898376 Chemotherapy for advanced gastric cancer: review and update of current practices. 2013 Jul 1
33 23963147 S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. 2013 Sep 17 1
34 24649158 A phase II study of S-1 in relapsed small cell lung cancer. 2013 Mar 1
35 21351099 Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. 2012 Jan 15 1
36 21647560 A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer. 2012 Mar 1
37 22172569 A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. 2012 Mar 1
38 22235991 S-1 as a core anticancer fluoropyrimidine agent. 2012 Mar 1
39 22353201 Pharmacokinetic study of weekly (days 1-5) low-dose S-1 in patients with non-small-cell lung cancer. 2012 May 1
40 22424872 A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. 2012 Nov 1
41 22740921 S-1 monotherapy for previously treated non-small cell lung cancer: A retrospective analysis by age and histopathological type. 2012 Feb 1
42 22860709 S-1 for the treatment of gastrointestinal cancer. 2012 Sep 1
43 22953663 Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer. 2012 Aug 2
44 22996786 [A case report of S-1 monotherapy for advanced hepatocellular carcinoma]. 2012 Sep 1
45 20605363 Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. 2011 May 1 1
46 21143703 Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients. 2011 Feb 1
47 21187666 Concurrent chemoradiotherapy with S-1 as first-line treatment for patients with oropharyngeal cancer. 2011 1
48 21325974 Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer. 2011 Apr 1
49 21659785 Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302). 2011 1
50 21675835 A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. 2011 Jun 2